Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
BACK TO LIST

Laboratory Report

Patient
Name: Begum, , Bethany,
DOB: 19-JAN-1976 (Age: 49)
Gender: female
Address:
Studio 22e
Joe unions
M1 Manchester (United Kingdom)
ID: 2365-936148-1 (ECI)
Report
Date: 03-MAR-2017
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Cornbrook Medical Practice
City Road 204
M3 3 Manchester (United Kingdom)
Specimen
Collected: 03-MAR-2017

Chemistry

Test 03-MAR-2017 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.3 H 4.8 - 5.7 %
Glucose [Mass/volume] in Blood 89.9 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 7.3 7 - 25 mg/dL
Creatinine [Mass/volume] in Blood 1.1 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.4 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 3.7 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 107.3 98 - 108 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.8 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 158.5 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 100.3 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 85.3 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 53.1 40 - 60 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
All parameters are within normal limits except for a mildly elevated HbA1c (6.3%), indicating impaired glucose metabolism or possible prediabetes. Renal function, electrolytes, and lipid profile are unremarkable. Recommend clinical correlation for glycemic status and consideration of lifestyle modification or further evaluation for diabetes risk.